Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
2001 1
2002 1
2003 1
2004 1
2005 2
2008 2
2009 2
2011 3
2012 4
2014 2
2015 2
2016 1
2017 1
2018 1
2019 1
2022 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Grfetic
Page 1
Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial.
Heise T, Mari A, DeVries JH, Urva S, Li J, Pratt EJ, Coskun T, Thomas MK, Mather KJ, Haupt A, Milicevic Z. Heise T, et al. Lancet Diabetes Endocrinol. 2022 Jun;10(6):418-429. doi: 10.1016/S2213-8587(22)00085-7. Epub 2022 Apr 22. Lancet Diabetes Endocrinol. 2022. PMID: 35468322 Clinical Trial.
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial.
Urva S, Coskun T, Loh MT, Du Y, Thomas MK, Gurbuz S, Haupt A, Benson CT, Hernandez-Illas M, D'Alessio DA, Milicevic Z. Urva S, et al. Lancet. 2022 Nov 26;400(10366):1869-1881. doi: 10.1016/S0140-6736(22)02033-5. Epub 2022 Oct 27. Lancet. 2022. PMID: 36354040 Clinical Trial.
Dulaglutide as add-on therapy to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes (AWARD-10): a 24-week, randomised, double-blind, placebo-controlled trial.
Ludvik B, Frías JP, Tinahones FJ, Wainstein J, Jiang H, Robertson KE, García-Pérez LE, Woodward DB, Milicevic Z. Ludvik B, et al. Lancet Diabetes Endocrinol. 2018 May;6(5):370-381. doi: 10.1016/S2213-8587(18)30023-8. Epub 2018 Feb 23. Lancet Diabetes Endocrinol. 2018. PMID: 29483060 Free article. Clinical Trial.
Art therapy may be benefitial for reducing stress--related behaviours in people with dementia--case report.
Mimica N, Kalinić D. Mimica N, et al. Psychiatr Danub. 2011 Mar;23(1):125-8. Psychiatr Danub. 2011. PMID: 21448117 Free article.
Non-pharmacological interventions may be beneficial in increasing the behavioural disturbances which appears frequently during the progression of dementia, and combination of non-pharmacological techniques and drugs is usually more efficacy than psychopharmacs alone. Mr. Zvonk …
Non-pharmacological interventions may be beneficial in increasing the behavioural disturbances which appears frequently during the progressi …
Croatia has reached iodine sufficiency.
Kusić Z, Novosel SA, Dabelić N, Punda M, Roncević S, Labar Z, Lukinac Lj, Nöthig-Hus D, Stanicić A, Kaić-Rak A, Mesaros-Kanjski E, Karner I, Smoje J, Milanović N, Katalenić M, Juresa V, Sarnavka V. Kusić Z, et al. J Endocrinol Invest. 2003 Aug;26(8):738-42. doi: 10.1007/BF03347356. J Endocrinol Invest. 2003. PMID: 14669828
28 results